Head of Oncology AstraZeneca UK
David Brocklehurst is the Head of Oncology at AstraZeneca and is responsible for driving AstraZeneca’s ambition to lead a revolution in oncology and ultimately eliminate cancer as a cause of death. As well as overseeing all aspects of its portfolio and pipeline in oncology, he leads the organisation in delivering its leadership initiatives aimed to deliver the best possible patient outcomes. This includes partnerships to help the NHS diagnose people with cancer, identify the right treatment for them earlier in their cancer journeys, and ensure that the cancer care pathways within the NHS are optimised to enable improved patient outcomes.
David has been with AstraZeneca for 13 years and has held roles of increasing responsibility that include leading global teams for breast cancer and immuno-oncology. In his previous role as Vice President, Oncology Business Unit Head for the Nordics, David was responsible for bringing all of AstraZeneca’s innovative oncology medicines to cancer patients in Denmark, Norway, Sweden, Finland and Iceland.